TP53 and neoplasm: Inspired by these findings, we further optimized the structure of L14 through the group substitution, resulting in the analog L14‐8, which demonstrated the enhanced anti‐tumor activity by targeting and activating the PLK1/TP53‐SAT1‐induced ferroptosis pathway.